from Yahoo Finance https://ift.tt/2YXxVPV
-
LabCorp expands availability of at-home sample collection kit for COVID-19 testing
from Yahoo Finance https://ift.tt/2T1fHcN
-
U.S. FDA declines to review Bristol Myers, bluebird therapy for multiple myeloma
from Yahoo Finance https://ift.tt/2WUgWeC
The Latest
-
This ASX ETF has generated returns of almost 15% per year!
-
Rio Tinto Q1 FY26: Production growth and steady guidance drive optimism
-
HUB24 grows Q3 inflows and funds under administration
-
2 ASX shares with dividend yields above 8%